✦ LIBER ✦

Liver Biochemical Course, Serum HBV DNA and Liver Stiffness Measurement for Therapeutic Decisions in HBeAg-Negative Chronic Hepatitis B Infection

✍ Scribed by Charatcharoenwitthaya, Phunchai ;Phisalprapa, Pochamana ;Rungkaew, Pimpattana ;Kajornvuthidej, Sorrayut ;Bandidniyamanon, Wimolrak ;Chainuvati, Siwaporn P. ;Pausawasdi, Nonthalee ;Nimanong, Supot ;Chotiyaputta, Watcharasak ;Leelakusolvong, Somchai ;Atisook, Kanit ;Tanwandee, Tawesak

Book ID: 122559775
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 465 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63720-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal changes in serum HBV DNA le

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection

✍ G. V. Papatheodoridis; N. Chrysanthos; E. Hadziyannis; E. Cholongitas; E. K. Man 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

The role of serial measurement of serum

The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(−) hepatitis B infection: Association with liver disease progression. A prospective cohort study

✍ George Zacharakis; John Koskinas; Stamatia Kotsiou; Fevronia Tzara; Nikolaos Vaf 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Is there a meaningful serum hepatitis B

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Ioannis S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

The diagnosis of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B indicating therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA >2,000 IU/mL. We evaluated the severity of liver histology and the presence of histological indication for treatment in patients with H

662 DO 4LOG10 IU/L SERUM HBV-DNA AND NOR

662 DO 4LOG10 IU/L SERUM HBV-DNA AND NORMAL ALANINE AMINOTRANSFERASE (ALT) LEVELS IDENTIFY CLINICALLY SIGNIFICANT HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) LIVER DISEASE IN HONG KONG?

✍ N. Leung; C. Yeung; R. Chan; S.M. Au; H. Poon; A.J. Hui 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

There were no differences in serum HBV D

There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume

✍ W.-M. Ke; S.-B. Xie; X.-J. Li; S.-Q. Zhang; J. Lai; Y.-N. Ye; Z.-L. Gao; P.-J. C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Corrigendum to “The role of serial measu

Corrigendum to “The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(−) hepatitis B infection: Association with liver disease progression. A prospective cohort study” [J Hepatol 49 (2008) 884–891]

✍ George Zacharakis; John Koskinas; Stamatia Kotsiou; Fevronia Tzara; Nikolaos Vaf 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB